Select Publications
Book Chapters
2008, 'Clinical Governance', in Advanced Renal Care, pp. 216 - 230, http://dx.doi.org/10.1002/9780470693995.ch15
,2008, 'Combination therapy for pulmonary arterial hypertension', in Pulmonary Arterial Hypertension, John Wiley & Sons Ltd, pp. 127 - 145
,2001, 'Right heart catheterisation and haemodynamic evaluation of the heart transplant patient', in Cardiology and cardiac catheterisation: the essential guide, edn. Original, Harwood Academic Publishers, Amsterdam, The Netherlands, pp. 295 - 302
,1997, 'Cardiac transplantation', in Thompson P (ed.), Coronary Care Manual, edn. 2nd Edition, Churchill Livingstone, New York NY, pp. 403 - 405
,1991, 'Cardiac transplantation: Australian results', in Artificial Heart 3, Springer Japan, pp. 257 - 262, http://dx.doi.org/10.1007/978-4-431-68126-7_30
,Journal articles
2024, 'Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension Therapy', Chest, 165, pp. 967 - 977, http://dx.doi.org/10.1016/j.chest.2023.10.037
,2024, 'Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension', Advances in Therapy, 41, pp. 1062 - 1074, http://dx.doi.org/10.1007/s12325-023-02769-7
,2024, 'Cost-Effectiveness of Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation in the Australian Health Care System', Heart Lung and Circulation, http://dx.doi.org/10.1016/j.hlc.2024.03.004
,2023, 'Orthotopic Heart Transplantation Followed By Autologous Stem Cell Transplantation in Patients with Cardiac AL Amyloidosis: Results from a Single Centre Prospective Study', Blood, 142, pp. 3414 - 3414, http://dx.doi.org/10.1182/blood-2023-184319
,2023, 'DMD-Associated Dilated Cardiomyopathy: Genotypes, Phenotypes, and Phenocopies', Circulation: Genomic and Precision Medicine, 16, pp. 421 - 430, http://dx.doi.org/10.1161/CIRCGEN.123.004221
,2023, 'Pre-operative pulmonary artery pulsatility index does not predict mortality post-cardiac transplantation', ESC Heart Failure, 10, pp. 1980 - 1986, http://dx.doi.org/10.1002/ehf2.14226
,2023, 'Tricuspid Regurgitation After Heart Transplantation: The Cause or the Result of Graft Dysfunction?', Transplantation, 107, pp. 1390 - 1397, http://dx.doi.org/10.1097/TP.0000000000004511
,2023, 'Post-Transplantation Outcomes of Adult Congenital Heart Disease', JOURNAL OF HEART AND LUNG TRANSPLANTATION, 42, pp. S444 - S445, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000992480601253&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2023, 'Routine Donor Specific Antibody Monitoring in Heart Transplant Recipients - Is There a Role?', JOURNAL OF HEART AND LUNG TRANSPLANTATION, 42, pp. S429 - S429, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000992480601222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2023, 'Acute Vasoreactivity Testing and Outcomes in Pulmonary Arterial Hypertension: A Call for Increased Testing', Heart Lung and Circulation, 32, pp. 156 - 165, http://dx.doi.org/10.1016/j.hlc.2022.09.005
,2023, 'Heart Transplantation from DCD Donors in Australia: Lessons Learned from the First 74 Cases', Transplantation, 107, pp. 361 - 371, http://dx.doi.org/10.1097/TP.0000000000004294
,2023, 'Rapid triage and transition to telehealth for heart transplant patients in the COVID-19 pandemic setting', Journal of Telemedicine and Telecare, http://dx.doi.org/10.1177/1357633X231151714
,2023, 'Combined Plasmapheresis and Complement Inhibition in a Highly Allosensitised Cardiac Transplant Recipient', Heart, Lung and Circulation, 32, pp. S147 - S148, http://dx.doi.org/10.1016/j.hlc.2023.06.057
,2023, 'Intensive Tacrolimus Level Monitoring After Itraconazole Prophylaxis Cessation Reduces Acute Cellular Rejection Following Heart Transplant', Heart, Lung and Circulation, 32, pp. S164 - S164, http://dx.doi.org/10.1016/j.hlc.2023.06.095
,2023, 'Routine Donor-Specific Antibody Monitoring in Heart Transplant Recipients: Is There a Role?', Heart, Lung and Circulation, 32, pp. S176 - S176, http://dx.doi.org/10.1016/j.hlc.2023.06.122
,2023, 'Spatial Assessment and Utility of Left Ventricular Strain by Magnetic Resonance Feature Tracking in Patients after Orthotopic Heart Transplantation for Diagnosis of Rejection', Heart, Lung and Circulation, 32, pp. S256 - S256, http://dx.doi.org/10.1016/j.hlc.2023.06.315
,2022, 'Pulmonary haemodynamics and pulmonary congestion: where are we now?', European Heart Journal, 43, pp. 4515, http://dx.doi.org/10.1093/eurheartj/ehac499
,2022, 'Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis', Internal Medicine Journal, 52, pp. 1826 - 1830, http://dx.doi.org/10.1111/imj.15926
,2022, 'Portopulmonary Hypertension: The Interplay Between the Liver and Pulmonary Arteries', Heart Lung and Circulation, 31, pp. 1185 - 1187, http://dx.doi.org/10.1016/j.hlc.2022.07.010
,2022, 'Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation', Circulation, 145, pp. 1811 - 1824, http://dx.doi.org/10.1161/CIRCULATIONAHA.121.057006
,2022, 'Impact of frailty on mortality and morbidity in bridge to transplant recipients of contemporary durable mechanical circulatory support', Journal of Heart and Lung Transplantation, 41, pp. 829 - 839, http://dx.doi.org/10.1016/j.healun.2022.02.008
,2022, 'Interplay of sex hormones and long-term right ventricular adaptation in a Dutch PAH-cohort', Journal of Heart and Lung Transplantation, 41, pp. 445 - 457, http://dx.doi.org/10.1016/j.healun.2021.11.004
,2022, 'Peripartum cardiomyopathy: a global effort to find the cause and cure for the rare and little understood disease', Biophysical Reviews, 14, pp. 369 - 379, http://dx.doi.org/10.1007/s12551-022-00930-0
,2022, 'Validation of Cognitive Impairment in Combination with Physical Frailty as a Predictor of Mortality in Patients with Advanced Heart Failure Referred for Heart Transplantation', Transplantation, 106, pp. 200 - 209, http://dx.doi.org/10.1097/TP.0000000000003669
,2022, 'Impact of Initial Therapeutic Strategy on Long-Term Outcomes in Pulmonary Arterial Hypertension: An Analysis of the PHSANZ Registry', Heart, Lung and Circulation, 31, pp. S86 - S86, http://dx.doi.org/10.1016/j.hlc.2022.06.095
,2021, 'Chronic thromboembolic pulmonary hypertension in Australia and New Zealand: An analysis of the PHSANZ registry', Respirology, 26, pp. 1171 - 1180, http://dx.doi.org/10.1111/resp.14162
,2021, 'Impact of left heart disease risk factors on risk stratification and treatment response in pulmonary arterial hypertension', EUROPEAN HEART JOURNAL, 42, pp. 1958 - 1958, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000720456902159&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Waitlist and post-transplant outcomes for eisenmenger syndrome: A comparison of transplant strategies', Journal of Heart and Lung Transplantation, 40, pp. 841 - 849, http://dx.doi.org/10.1016/j.healun.2021.04.005
,2021, 'Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study', Journal of Heart and Lung Transplantation, 40, pp. 494 - 503, http://dx.doi.org/10.1016/j.healun.2021.02.006
,2021, 'Everolimus for the Prevention of Calcineurin-Inhibitor-Induced Left Ventricular Hypertrophy After Heart Transplantation (RADTAC Study)', JACC: Heart Failure, 9, pp. 301 - 313, http://dx.doi.org/10.1016/j.jchf.2021.01.007
,2021, 'Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry', Respiratory Medicine, 178, http://dx.doi.org/10.1016/j.rmed.2020.106220
,2021, 'The impact of frailty on mortality after heart transplantation', Journal of Heart and Lung Transplantation, 40, pp. 87 - 94, http://dx.doi.org/10.1016/j.healun.2020.11.007
,2020, 'Abstract 14268: Responses to Exercise During Right Heart Catheterisation in Pulmonary Hypertension', Circulation, 142, http://dx.doi.org/10.1161/circ.142.suppl_3.14268
,2020, 'Pre-operative pulmonary artery pulsatility index does not predict mortality post cardiac transplantation but PVR is a prognostic tool in LVAD-bridged patients', European Heart Journal, 41, http://dx.doi.org/10.1093/ehjci/ehaa946.2228
,2020, 'Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and Challenges', Heart Lung and Circulation, 29, pp. 1459 - 1468, http://dx.doi.org/10.1016/j.hlc.2020.01.017
,2020, 'Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registry', Respirology, 25, pp. 863 - 871, http://dx.doi.org/10.1111/resp.13768
,2020, 'In Honour of Professor Cristobal dos Remedios on behalf of the MAWA Trust', Biophysical Reviews, 12, pp. 765 - 766, http://dx.doi.org/10.1007/s12551-020-00746-w
,2020, 'Pulmonary arterial hypertension with below threshold pulmonary vascular resistance', European Respiratory Journal, 56, http://dx.doi.org/10.1183/13993003.01654-2019
,2020, 'Combination therapy with oral treprostinil for pulmonary arterial hypertension: A double-blind placebo-controlled clinical trial', American Journal of Respiratory and Critical Care Medicine, 201, pp. 707 - 717, http://dx.doi.org/10.1164/rccm.201908-1640OC
,2020, 'Long-term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, tolerability, and pharmacokinetics', Pulmonary Circulation, 10, http://dx.doi.org/10.1177/2045894019866335
,2020, 'Retrospective Validation of the REVEAL 2.0 Risk Score With the Australian and New Zealand Pulmonary Hypertension Registry Cohort', Chest, 157, pp. 162 - 172, http://dx.doi.org/10.1016/j.chest.2019.08.2203
,2020, '063 A Case of Chronic Thromboembolic Pulmonary Hypertension in a Heart Transplant Patient, Successfully Treated With Pulmonary Endarterectomy', Heart, Lung and Circulation, 29, pp. S65 - S65, http://dx.doi.org/10.1016/j.hlc.2020.09.070
,2020, '158 Reconsidering the Threshold: Should Pulmonary Vascular Resistance >2 Wood Units be Considered Pulmonary Hypertension?', Heart, Lung and Circulation, 29, pp. S106 - S106, http://dx.doi.org/10.1016/j.hlc.2020.09.165
,2019, '4974Waitlist outcomes for Eisenmengers patients listed for bilateral sequential lung transplant or heart-lung transplant', European Heart Journal, 40, http://dx.doi.org/10.1093/eurheartj/ehz746.0033
,2019, 'Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: Results from a phase 2 randomised, parallel group, placebo-controlled trial', European Respiratory Journal, 54, http://dx.doi.org/10.1183/13993003.01030-2019
,